Navigation Links
Existing Radiation Countermeasures Inadequate! Development of Rx100 Promises Change!
Date:3/19/2011

JOHNSON CITY, Tenn., March 19, 2011 /PRNewswire/ -- Recent events in Japan have caused the world to focus on unintended radiation exposure. Exposure to radiation can be a cause for concern – especially if radiation levels reach or exceed 1 Gy. Radiation targets rapidly proliferating cells of the body. Cells of the hematopoietic system (bone marrow) and the gastrointestinal (GI) tract are two such cell types. Damage to these cells initiates programmed cell death (apoptosis).

First responders, healthcare professionals, and citizens lack sufficient medications to prevent cellular damage and death due to exposure to significant levels of whole-body irradiation. Agents that protect from radiation exposure are divided into three categories: 1) Agents that must be administered before cellular exposure to ionizing radiation or "radioprotectants;" 2) Agents that can be administered after exposure and which will forestall the cascade of events leading to radiation-induced damage or "radiomitigants;" and 3) Agents that can facilitate or promote endogenous recovery from radiation-induced damage or "regenerators."

To date, the FDA has approved a few radioprotectants. These include:

  • Prophylactic potassium iodide to protect the thyroid from exposure to excess I 132.
  • Laxatives and chelating agents (i.e. diethylene triamine pentaacetic acid ("DTPA"), etc., to decrease exposure by binding and promoting urinary excretion.
  • Absorbing agents such as Prussian Blue to limit GI absorption or high oral doses of calcium to compete with intestinal absorption of milk contaminated with strontium 90.

There are a small handful of agents presently under development as radiomitigants. These include Rx100. Although under development, this product shows significant promise because of its ability to be administered up to 72 hrs.(1) after exposure to high levels of radiation ̵
'/>"/>

SOURCE RxBio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Elusys Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax
2. Yongye International Expands Its Existing Production Capacity by 50% and Provides Updates on Customer List Acquisition
3. Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
4. ChemImage Works to Improve Existing Methods of Imaging Untreated Fingerprints on Paper Substrates
5. Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
6. Australian Patent Issued to CreAgri® for Ultraviolet Radiation (UVR) Protection by its Hydroxytyrosol-Based Formulations
7. Bolder BioTechnology Receives $1.2 Million from NIH to Study Long-Acting G-CSF and GM-CSF Analogs in Treating Acute Radiation Syndrome
8. Rx100 Rescues Life if Administered Up to 72 Hours After Exposure to Lethal, Whole-Body Radiation!
9. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
10. Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy Market
11. New near-field radiation therapy promises relief for overheating laptops
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Institute of Standards and Technology (NIST) and California ... design for an atomic clock that is based ... , The microcomb clock, featured on the cover ... Optica ,* is the first demonstration of ... conversion of optical frequencies to lower microwave frequencies. ...
(Date:7/22/2014)... 2014 CTD Holdings, Inc. (OTCQB:CTDH), a ... device, cosmetics, and other markets, announced today that it ... of qualified private investors led by Novit L.P., an ... The transaction involved the signing of a Securities Purchase ... Common Stock at a price per share of $1.00, ...
(Date:7/22/2014)... July 22, 2014 OHAUS Corporation, ... and mechanical balances and scales, proudly announces its ... won Laboratory Equipment magazine’s 2014 “Readers' Choice” Award ... consecutive year the Explorer was voted the best ... Readers’ Choice Awards celebrates “excellence in product design ...
(Date:7/22/2014)... Mass. and SHENZHEN, China ... Tech Solutions Co., LTD, (BGI Tech), a subsidiary ... today the global launch of a new human ... industry-leading platform. This newly offered service includes in-depth ... at reduced prices until December 31, 2014. ...
Breaking Biology Technology:'Comb on a chip' powers new NIST/Caltech atomic clock design 2CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3
... Jan. 30 Monogram,Biosciences, Inc., (Nasdaq: MGRM ) ... February 7, 2008 at 4:30 p.m. (Eastern Time) to ... outlook for 2008.,The call will be hosted by Mr. ... participate in the live teleconference, please call (877) 545-1409,or ...
... Helix BioPharma Corp. (TSX: HBP / Frankfurt: WKN ... Helix BioPharma Corp.,announces that at the Company,s Annual ... all of the resolutions presented by,management, appointing KPMG ... Cawkell, Jack Kay, Slawomir Majewski, and Gordon Lickrish ...
... 30 In a letter to,Governor Jennifer Granholm ... the Governor,s State of the State Address,wherein she ... MichBio is the,statewide association for Michigan,s life sciences ... of the legislature, to diversify,the state,s economy by ...
Cached Biology Technology:Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call 2Helix BioPharma shareholders vote in favour of management 2MichBio Responds to Governor's Plan to Repeal Tort Reform Laws 2
(Date:7/22/2014)... promise for treating damaged organs and tissues, but with ... their effectiveness. New methods are being developed and tested ... after transplantation, as described in a Review article in ... Mary Ann Liebert, Inc., publishers. The article is available ... website . , In the article ,Preconditioning ...
(Date:7/22/2014)... Cambridge, MA and Shenzhen, China July 22, ... Tech), a subsidiary of BGI, the world,s largest ... a new human whole exome sequencing service based ... service includes in-depth bioinformatics analysis and SNP validation, ... 31, 2014. , Complete Genomics, highly regarded ...
(Date:7/22/2014)... a place emerging as a world-famous vacation spot with natural ... on the island. The Korea Institute of Geoscience and Mineral ... that a recent volcanic eruption was evident 5,000 years ago. ... date when lava spewed out of a volcano 5,000 years ... as the one the whole peninsula. , The research team ...
Breaking Biology News(10 mins):BGI Tech launches human whole exome sequencing service on complete genomics' advanced platform 2Jeju Island is a live volcano 2
... case state-of-the-art energy efficient housing will be officially opened ... Nottingham. The house built by BASF, a major ... part of the Creative Energy Homes Project on University ... of Built Environment to stimulate sustainable design ideas and ...
... Heritage Foundation (CHF) announced that Leroy Hood ... Award. Jointly sponsored by the Pittsburgh Conference ... and CHF, this award recognizes outstanding individuals ... community, inspired achievement, promoted public understanding of ...
... Ala. The long-sought-after biological gateway that anthrax uses ... at the University of Alabama at Birmingham (UAB). ... a receptor that sits on the surface of certain ... exactly how the bacteria get inside cells to begin ...
Cached Biology News:Opening day for a home of the future 2Opening day for a home of the future 3Leroy Hood to receive 2008 Pittcon Heritage Award 2Leroy Hood to receive 2008 Pittcon Heritage Award 3Anthrax cellular entry point uncovered 2
...
Mynox is intended for research use only. Mynox is used for the elimination of Mycoplasma and Acholeplasma in cell and virus cultures, and other biologicals....
... Acridinium NHS ester can be ... nucleic acids. The covalently bound ... chemiluminescence in the presence of ... proteins can be used as ...
... The electrophoretic mobility shift assay (EMSA) is ... Often referred to as gel shift or ... the principle that when subjected to electrophoresis, ... DNA-protein complex. The Pierce LightShift Chemiluminescent EMSA ...
Biology Products: